Remsima™ SC

INN: infliximab

Approved for use in:

Crohn’s Disease (moderate-severe)
Ulcerative Colitis (moderate-severe)

Type/Class

Biosimilar

Delivery Route

Subcutaneous Injection

Health Canada Approval

2021

Storage

Refrigerate between 2 and 8°C, do not freeze, keep in original carton to protect from light, may be stored at room temperature (up to 25°C) for a single period of up to 28 days.

Use in Older Adults (65+)

May be used, please consult your doctor.

Pregnancy Indication

Infants may be at increased risk for infection.

Breastfeeding Indication

Low exposure levels due to degradation by GI tract.

Pediatric Indication

Not authorized.

Learn More

View the Remsima™ SC product monograph.